Tau Antibody–Targeting Pathological Species Block Neuronal Uptake and Interneuron Propagation of Tau in Vitro.
Science Direct Pathology; http://doi.org/10.1016/j.ajpath.2017.01.022.
Tau phosphorylation induced by severe closed head traumatic brain injury is linked to the cellular prion protein.
BioMed Central; 10.1186/s40478-017-0435-7.
Restoring the Processivity of Kinesin Nanomotors.
Advanced Biosystems; https://doi.org/10.1002/adbi.201600034.
Microtubule density and landing rate as parameters to analyze tau protein in the MT-kinesin “gliding” assay.
Sensors and Actuators B: Chemical; https://doi.org/10.1016/j.snb.2016.07.082.
Widespread tau seeding activity at early Braak stages.
Acta Neuropathologica; doi: 10.1007/s00401-016-1644-z.
Extended Postnatal Brain Development in the Longest-Lived Rodent: Prolonged Maintenance of Neotenous Traits in the Naked Mole-Rat Brain.
Front Neurosci.; DOI: 10.3389/fnins.2016.00504.
Naturally Occurring Autoantibodies against Tau Protein Are Reduced in Parkinson's Disease Dementia.
PLOS ONE; http://dx.doi.org/10.1371/journal.pone.0164953.
Inactivation of Prions and Amyloid Seeds with Hypochlorous Acid
PLOS Pathogens; http://dx.doi.org/10.1371/journal.ppat.1005914.
miR-106b inhibits tau phosphorylation at Tyr18 by targeting Fyn in a model of Alzheimer's disease.
Biochemical and Biophysical Research Communications; doi: 10.1016/j.bbrc.2016.08.037.
Pathological α-synuclein transmission initiated by binding lymphocyte-activation gene 3
Science; 10.1126/science.aah3374.
 
	
	
         
      